期刊文献+

RNAi重组体抑制白血病K562细胞系中NPM1基因的表达 被引量:3

RNA interference silencing nucleophosmin 1 inhibits NPM1 gene expression in K562 cells
下载PDF
导出
摘要 目的构建核仁磷酸蛋白1(nucleophosmin1,NPM1)特异性的RNAi真核表达载体,观察对白血病K562细胞系NPM1表达的抑制作用。方法采用RT-PCR检测白血病细胞系(THP1和K562)和急性髓系白血病(AML)细胞NPM1mRNA水平。设计合成2条针对NPM1基因并具有小发夹结构的DNA序列,经退火形成互补双链,再克隆至载体pGenSil-1中构建含NPM1的RNAi重组体,经酶切及测序鉴定后通过脂质体转染K562细胞,同时设立pGenSil-1转染组和pGenSil-1/neg转染组。采用RT-PCR检测各组转染细胞中NPM1的mRNA水平。结果白血病细胞系和AML细胞均高表达NPM1 mRNA。针对人NPM1基因的RNAi重组体构建成功,并能够稳定转染K562细胞,导致白血病细胞NPM1mR-NA相对表达量下降64%,而pGenSil-1转染组和pGenSil-1/neg转染组未能下调NPM1表达。结论白血病细胞高表达NPM1基因,其mRNA表达水平能够被靶向NPM1的RNAi重组体特异性地下调。 Objective To construct eukaryotic expression vector of RNAi specific to nucleophosminl ( NPM1 ) and investigate the effect of recombinant plasmid on NPM1 expression in K562 cells. Methods The expression level of NPM1 mRNA was detected by RT-PCR in leukemia cell lines (THP1 and K562), bone marrow or blood samples from 5 patients with acute myelogenous leukemia (AML) and from 5 healthy subjects. A short hairpin RNA targeting NPM1 was synthesized and inserted into the plasmid pGenSil-1. After the recombinant plasmid was identified, the correct plasmid was transfected into K562 cells, then the expression level of NPM1 mRNA was detected by RT-PCR. Results NPM1 mRNA levels were higher in two leukemia cell lines and all AML samples than those in normal cells. The RNAi recombinant plasmid was constructed successfully. The NPM1 mRNA levels decreased by 64% in K562 cells after the recombinant plasmid transfection, but those were not inhibited in K562 cells transfected with empty plasmid and untransfected K562 cells. Conclusion NPM1 mRNA is overexpressed in leukemia cells. The RNAi recombinant targeting NPM1 suppresses the expression of NPM1 mRNA.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2008年第10期938-941,共4页 Journal of Third Military Medical University
基金 重庆市教委科学技术研究基金(KJ050309)~~
关键词 核仁磷酸蛋白1 RNA干扰 白血病 K562细胞 nucleophosmin 1 RNA interference leukemia K562 cells
  • 相关文献

参考文献13

  • 1Li J, Sejas D P, Rani R, et al. Nucleophosmin regulates cell cycle progression and stress response in hematopoietic stem/progenitor cells [J]. J Biol Chem, 2006, 281(24) : 16536 -16545. 被引量:1
  • 2Falini B, Mecucci C, Tiacci E, et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype [J]. N Engl J Med, 2005, 352(3): 254-266. 被引量:1
  • 3Grisendi S, Pandolfi P P. NPM mutations in acute myelogenous leukemia[J]. N Engl J Med, 2005, 352(3) : 291 -292. 被引量:1
  • 4Li J, Zhang X, Sejas D P, et al. Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells[J]. Leuk Res, 2005, 29(12) : 1415 - 1423. 被引量:1
  • 5Grisendi S, Bernardi R, Rossi M, et al. Role of nucleophosmin in embryonic development and tumorigenesis [ J ]. Nature, 2005, 437 (7055) : 147 - 153. 被引量:1
  • 6Colombo E, Bonetti P, Lazzerini-Denchi E, et al. Nucleophosmin is required for DNA integrity and p19Arf protein stability [J]. Mol Cell Biol, 2005, 25(20): 8874-8886. 被引量:1
  • 7Yun J P, Miao J, Chen G G, et al. Increased expression of nucleophosmin/B23 in hepatocellular carcinoma and correlation with clinicopathological parameters [ J ]. Br J Cancer, 2007, 96 (3) : 477 - 484. 被引量:1
  • 8Gu T L, Tothova Z, Scheijen B, et al. NPM-ALK fusion kinase of anaplastic large-cell lymphoma regulates survival and proliferative signaling through modulation of FOXO3a[J]. Blood, 2004, 103 (12) : 4622 - 4629. 被引量:1
  • 9Thiede C, Koch S, Creutzig E, et al. Prevalence and prognostic impact of NPMI mutations in 1485 adult patients with acute myeloid leukemia (AML) [J]. Blood, 2006, 107(10): 4011 -4020. 被引量:1
  • 10Kondo T, Minamino N, Nagamura-Inoue T, et al. Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity [J]. Oncogene, 1997, 15(11): 1275-1281. 被引量:1

同被引文献38

  • 1李明,汪明春,张琼丽,杜新.组胺H_2受体阻滞剂阻断再生障碍性贫血患者CD_8^+细胞抑制正常CFU-Mk生长的作用[J].中国病理生理杂志,2005,21(5):936-938. 被引量:1
  • 2Kubota T, Fujiwara H, Ueda Y, et al. Cimetidine modulates the antigen presenting capacity of dendritic cells from colorectal cancer patients [J]. Br J Cancer, 2002, 86(8): 1257 -1261. 被引量:1
  • 3Wang J, Su B, Ding Z, et al . Cimetidine enhances immune response of HBV DNA vaccination via impairment of the regulatory function of regulatory T cells [ J ]. Biochem Biophys Res Commun, 2008, 372 (3) : 491 -496. 被引量:1
  • 4Asakage M, Tsuno N H, Kitayama J, et al . The effect of cimetidine mainly increases CD4^+ cells of peripheral blood T lymphocytes [ J]. Gan To Kagaku Ryoho, 2005, 32( 11 ) : 1576 - 1577. 被引量:1
  • 5Gantner F, Sakai K, Tusche M W,et al . Histamine h(4) and h(2) receptors control histamine-induced interleukin-16 release from human CD8( + ) T cells[J].J Pharmacol Exp Ther, 2002, 303(1) : 300- 307. 被引量:1
  • 6Assaf C, Hummel M, Dippel E, et al. High detection rate of T-cell receptor beta chain rearrangements in T-cell lymphoproliferations by family specific polymerase chain reaction in combination with the GeneScan technique and DNA sequencing[J]. Blood, 2000, 96(2): 640 - 646. 被引量:1
  • 7Jiang Y Z, Mavroudis D A,Dermime S,et al. Preferential usage of T cell receptor (TCR) V beta by allogeneic T cells recognizing myeloid leukemia cells : implications for separating graft-versus-leukemia effect from graft-versus-host disease[ J] . Bone Marrow Transplant, 1997, 19 (9) : 899 - 903. 被引量:1
  • 8Elenkov I J, Webster E, Papanicolaoa D A, et al. Histamine potently suppresses human IL-2 and stimulates IL-10 production via H2 receptors[ J]. The Journal of Immunology, 1988, 161 (5) : 2586 -2593. 被引量:1
  • 9Falini B, Mecucci C, Tiacci E, et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype [ J ]. N Engl J Med, 2005, 352(3): 254-266. 被引量:1
  • 10Zhang Y, Zhang M, Yang L, et al. NPM1 mutations in myelodysplastic syndromes and acute myeloid leukemia with normal karyotype [ J ]. Leuk Res, 2007, 31(1) : 109 -111. 被引量:1

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部